Showing results (241-250 of 419) with videos related to
Sort By:
Pageof 42
Gynecologic Oncology Research and Practice|May 28, 2016
Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experienceSiqing Fu, Naiyi Shi, Jennifer Wheler, et al.JCO Precision Oncology|September 11, 2020
Phase I Study of the BRAF Inhibitor Vemurafenib in Combination With the Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With BRAF-Mutated MalignanciesVivek Subbiah, Shiraj Sen, Kenneth R Hess, et al.British Journal of Cancer|March 6, 2021
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignanciesShuyang Yao, Filip Janku, Vivek Subbiah, et al.Molecular Cancer Therapeutics|December 15, 2017
Phase I Dose-Escalation Study of Anti-CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced CancersDivya Sakamuri, Isabella C Glitza, Sonia L Betancourt Cuellar, et al.Plos One|March 4, 2014
FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitorsDenis L Jardim, Jennifer J Wheler, Kenneth Hess, et al.Expert Review of Anticancer Therapy|December 11, 2024
Lurbinectedin is an effective alternative to platinum rechallenge and may restore platinum sensitivity in patients with sensitive relapsed small cell lung cancerManuel Dómine Gómez, Vivek Subbiah, Solange Peters, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid CancerVivek Subbiah, Robert J Kreitman, Zev A Wainberg, et al.International Journal of Radiation Oncology, Biology, Physics|November 23, 2011
Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgeryChelsea C Pinnix, Hiral P Fontanilla, Andrea Hayes-Jordan, et al.The Oncologist|December 8, 2017
Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell TumorBrian A Menegaz, Branko Cuglievan, Jalen Benson, et al.Investigational New Drugs|April 24, 2015
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapyHeloisa Veasey Rodrigues, Danxia Ke, JoAnn Lim, et al.Pageof 42